$NAHD
New Asia Holdings Inc

2023 Q1 Form 10-Q Financial Statement

#000109690623001360 Filed on June 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $57.15K $46.61K
YoY Change 22.61% -4.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $57.15K $46.61K
YoY Change 22.61% -4.41%
Operating Profit -$57.15K -$46.61K
YoY Change 22.62%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$57.15K -$46.61K
YoY Change 22.61% -4.41%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$57.15K -$46.61K
YoY Change 22.61% -4.41%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$619.10
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.47K $39.59K
YoY Change -50.82% -69.26%
Cash & Equivalents $19.47K $39.59K
Short-Term Investments
Other Short-Term Assets $9.480K $10.80K
YoY Change -12.22% 16.13%
Inventory
Prepaid Expenses $9.480K
Receivables
Other Receivables
Total Short-Term Assets $28.95K $50.39K
YoY Change -42.55% -63.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.00 $200.00
YoY Change 0.0% 0.0%
Total Long-Term Assets $200.00 $200.00
YoY Change 0.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $28.95K $50.39K
Total Long-Term Assets $200.00 $200.00
Total Assets $29.15K $50.59K
YoY Change -42.38% -63.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $280.5K $197.9K
YoY Change 41.71% 48.14%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.241M $1.114M
YoY Change 11.38% 6.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.241M $1.114M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.241M $1.114M
YoY Change 11.38% 6.12%
SHAREHOLDERS EQUITY
Retained Earnings -$12.70M
YoY Change
Common Stock $75.29K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.212M -$1.064M
YoY Change
Total Liabilities & Shareholders Equity $29.15K $50.59K
YoY Change -42.38% -63.41%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$57.15K -$46.61K
YoY Change 22.61% -4.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$5.400K -$18.29K
YoY Change -70.48% -44.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -5.400K -18.29K
Cash From Investing Activities
Cash From Financing Activities 15.00K 0.000
Net Change In Cash 9.600K -18.29K
YoY Change -152.49% -74.46%
FREE CASH FLOW
Cash From Operating Activities -$5.400K -$18.29K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55410
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
NEW ASIA HOLDINGS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0460095
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
80 Tras Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
#01-03
CY2023Q1 dei Entity Address Country
EntityAddressCountry
SG
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
079019
CY2023Q1 dei Country Region
CountryRegion
65
CY2023Q1 dei City Area Code
CityAreaCode
6820
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
8885
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75288667 shares
CY2023Q1 us-gaap Cash
Cash
19474 usd
CY2022Q4 us-gaap Cash
Cash
9833 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9480 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13035 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
28954 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22868 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
195 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
195 usd
CY2023Q1 us-gaap Assets
Assets
29149 usd
CY2022Q4 us-gaap Assets
Assets
23063 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
280514 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
248797 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-46606 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-57150 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-46606 usd
CY2023Q1 fil Advance From Shareholder
AdvanceFromShareholder
960704 usd
CY2022Q4 fil Advance From Shareholder
AdvanceFromShareholder
945704 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1241218 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1194501 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1241218 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1194501 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75288667 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75288667 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75288667 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75288667 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
75289 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
75289 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11416188 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11399713 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12703184 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12646034 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-362 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1212069 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1171438 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29149 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23063 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
33017 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
19864 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
8401 usd
CY2022Q1 us-gaap Selling Expense
SellingExpense
8401 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15732 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18341 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
57150 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
46606 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-57150 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-57150 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-46606 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57106 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-46617 usd
CY2023Q1 fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0.00
CY2022Q1 fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0.00
CY2023Q1 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
CY2022Q1 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-57150 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-46606 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3555 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3330 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
48192 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24987 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5403 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18289 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15000 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9641 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18300 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9833 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57888 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19474 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39588 usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
818 usd
CY2023Q1 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd
CY2022Q1 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1017191 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-11 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-46606 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1063808 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1171438 usd
CY2023Q1 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
44 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-57150 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1212069 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-align:justify">Use of Estimates</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact our business, financial condition, and results of operations is highly uncertain and subject to change. We considered the potential impact of the COVID-19 pandemic on our estimates and assumptions and there was not a material impact to our unaudited consolidated financial statements as of and for the three months ended March 31, 2023; however, actual results could differ from those estimates and there may be changes to our estimates in future periods.</p>
CY2022Q1 us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
15000 usd
CY2022Q1 us-gaap Increase Decrease In Due To Officers And Stockholders Current
IncreaseDecreaseInDueToOfficersAndStockholdersCurrent
0 usd
CY2023Q1 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
960704 usd
CY2022Q4 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
945704 usd
CY2023Q1 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
960704 usd
CY2023Q1 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd

Files In Submission

Name View Source Status
0001096906-23-001360-index-headers.html Edgar Link pending
0001096906-23-001360-index.html Edgar Link pending
0001096906-23-001360.txt Edgar Link pending
0001096906-23-001360-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nahd-20230331.htm Edgar Link pending
nahd-20230331.xsd Edgar Link pending
nahd_ex31z1.htm Edgar Link pending
nahd_ex31z2.htm Edgar Link pending
nahd_ex32z1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nahd-20230331_lab.xml Edgar Link unprocessable
nahd-20230331_pre.xml Edgar Link unprocessable
nahd-20230331_htm.xml Edgar Link completed
nahd-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nahd-20230331_def.xml Edgar Link unprocessable